Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa
Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa
批准号:
10623270
负责人:
Helen Byakwaga
金额:
$10.13万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-08-25 至 2026-05-31
关键词:
AIDS related cancerAddressAdultAfricaAfrica South of the SaharaAlgorithmsAttenuatedAwardBiologicalBiological MarkersCD4 Positive T LymphocytesCell CountCessation of lifeClinicalClinical ManagementClinical ResearchDataDedicationsDevelopmentDevelopment PlansDiagnosisDiseaseDisease ProgressionEpidemiologyEtiologyFundingFutureGeneral PopulationGoalsHIVHIV InfectionsHIV diagnosisHIV-1Human Herpesvirus 8ImmuneImmunologic SurveillanceIncidenceIndividualInfectionIntegration Host FactorsInternationalInterventionInvestmentsKaposi SarcomaKnowledge acquisitionLaboratoriesLearningLinkLymphopeniaMalignant - descriptorMalignant NeoplasmsMeasurementMediatingMentorsMentorshipMetabolicMorbidity - disease rateMortality DeterminantsNatureNewly DiagnosedPathway interactionsPatientsPersonsPlasmaPlayPopulationPublic HealthRNAReportingResearchResearch PersonnelResearch ProposalsResearch TrainingResourcesRiskRoleScientistTestingTimeViralViral Load resultViremiaVirus ReplicationWorkanticancer researchantiretroviral therapycancer diagnosiscareercareer developmentclinically relevantco-infectioneffective interventionexperiencehigh riskimmune functionimprovedimproved outcomemortalitymortality riskpoint of carepredictive modelingreconstitutionresearch and developmentresponseskillssurvival predictionsystemic inflammatory responsetherapy development
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Project Summary
Among malignant complications of HIV infection in sub-Saharan Africa, one of the most common cancers
in the pre-antiretroviral therapy (ART) era — Kaposi’s sarcoma (KS) — continues to be amongst the
most common in the ART era. Despite a decline in mortality in the ART era, KS survival is still
unacceptably poor, and many questions remain regarding mortality after KS diagnosis in the ART era.
These questions span epidemiology and clinical management. With much yet to be learned, and as a
direct response to the urgent need for effective strategies to improve survival of patients with HIV-related
KS, the overall goal of this mentored career development proposal is to support Dr. Helen Byakwaga in
acquiring the knowledge and skills to become an independent investigator in clinical and translational
HIV-associated cancer research, with a focus on efforts to reduce KS mortality among HIV-infected
individuals in Sub-Saharan Africa. Dr. Byakwaga has developed a research proposal linked to a career
development plan, both of which are supported by a multi-faceted mentoring team that will guide her in
completing the research and transitioning to an internationally competitive independent scientist.
The specific aims are:
Aim 1: Determine excess risk of mortality associated with KS among HIV-infected adults in East Africa;
Aim 2: Identify potential biologic determinants of mortality among HIV-infected adults with a new
diagnosis of KS; and
Aim 3: Develop and validate a prediction model for mortality among individuals with HIV-related KS
This project will determine the true magnitude of the impact of KS on mortality among HIV-infected
individuals in the ART era, identify potential pathways that can be targeted to attenuate KS progression,
and develop an algorithm to predict those at highest risk for death after KS diagnosis and for whom rapid
interventions are most warranted. Overall, this proposal describes a comprehensive menu of research
and career development activities consisting of mentoring and coursework that will help Dr. Byakwaga to
achieve her research objectives and become an independent researcher.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Quantifying, Explaining and Predicting Survival After Diagnosis of HIV-related Kaposi Sarcoma in East Africa
-
批准号:10296754
-
项目类别:
-
资助金额:$10.29万
-
财政年份:2021
-
负责人:Helen Byakwaga
-
依托单位:
海外基金